Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer
Dr Etienne Brain speaks to ecancer about the final results from a phase III randomised clinical trial of adjuvant endocrine therapy.
The benefit of adjuvant chemotherapy in addition to endocrine therapy remains controversial for patients aged ≥ 70 years with oestrogen receptors-positive (ER+) HER2-negative (HER2-) breast cancer.
Dr Brain concludes by explaining they did not find a statistically significant OS benefit with the addition of CT to ET after surgery for ER+ HER2- BC with a high GGI.
Watch video Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer online without registration, duration hours minute second in high quality. This video was added by user ecancer 15 June 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 67 once and liked it people.